ClinicalTrials.Veeva

Menu

Community and Familial Impacts of the Opioid Crisis

Cambridge Health Alliance logo

Cambridge Health Alliance

Status

Active, not recruiting

Conditions

Overdose of Opiate
Bereavement
Opioid Use Disorder

Treatments

Other: Survey

Study type

Observational

Funder types

Other

Identifiers

NCT05116852
CHA-IRB-20-21-7

Details and patient eligibility

About

This study aims to analyze the needs of those who have lost a loved one to opioid-related death and/or those currently supporting a loved one in treatment for Opioid Use Disorder. Mental health status related to the death or support of a loved one will be assessed through a survey and through the use of several modules of the CAT-MH (computerized adaptive testing-mental health suite) questionnaire.

Full description

This study aims to establish the level of needs in the community among those who have lost loved ones to opioid overdose and/or currently support those in opioid addiction recovery. This study aims to analyze the needs of those who have lost a loved one to opioid-related death and/or those currently supporting a loved one in treatment for Opioid Use Disorder. The study will evaluate the mental health status for each study participant through a primary survey as well as current participant mental health status through the use of several modules of the CAT-MH adaptive testing questionnaire. CAT-MH will be used to rapidly measure severity levels of depression, anxiety, and substance use risk after participants complete the primary survey. The primary survey assesses the immediate impact of overdose death by a loved one and recognition of the onset of opioid addiction in the years after the event on family and community members. The primary survey will compare the impact of loss and/or recovery support on mental health and substance use at specified time points before and after the loss and/or an individual finding out about a loved one's opioid addiction. The primary survey will also evaluate attitudes in this population about mindfulness and self-compassion skills training, openness to technology and various treatment options, current and past levels of depression, anxiety and grief, as well as thematic areas of need specific to those who have lost a loved one to opioid overdose and/or currently support a loved one in opioid addiction recovery.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 18+, inclusive, who are competent, wish to participate and willing to provide informed consent
  • Willing and able to participate in completing the surveys using the internet on via smartphone as requested
  • Identify in one of the 3 groups: (a) Adults who have lost a direct relative or friend to opioid overdose or opioid-related death prior to taking the survey; (2) Adults who are currently supporting a loved one with active opioid addiction; (3) Adults who have lost a direct relative or friend to opioid overdose or opioid related death at least six months prior to survey participation and also currently support a loved one in active addiction recovery.

Exclusion criteria

  • Inability to complete the survey
  • Inability to speak, read, and understand English

Trial design

300 participants in 3 patient groups

Both grieving a loved one to opioid-related death and have an actively using loved one
Description:
These individuals will complete the study survey for their designated experience both supporting a loved one in treatment for Opioid Use Disorder, and having lost a loved one to opioid-related death.
Treatment:
Other: Survey
Individuals supporting a loved one in treatment for Opioid Use Disorder
Description:
These individuals will complete the study survey for their designated experience supporting a loved one in treatment for Opioid Use Disorder.
Treatment:
Other: Survey
Individuals grieving a loved one to opioid-related death
Description:
These individuals will complete the study survey for their designated experience losing a loved one to opioid-related death.
Treatment:
Other: Survey

Trial contacts and locations

1

Loading...

Central trial contact

Alexandra Comeau; Liz Gracey

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems